Vaccination

AstraZeneca starts trial of COVID antibody treatment

British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus. Aug 25, 2020